GE HealthCare Technologies stock (US36266G1076): Norges Bank stake adds spotlight after Q1 2026 earnings miss

GE HealthCare Technologies shares on the Nasdaq Global Select Market are drawing fresh attention from United States investors after Norges Bank disclosed a sizable new position and the company reported Q1 2026 results with earnings per share below Wall Street forecasts but revenue slightly ahead of expectations.

According to a filing summarized by MarketBeat on 06/01/2026, Norges Bank purchased 7,266,808 shares of GE HealthCare Technologies, with the stake valued at about USD 596,024,000 at the time of disclosure, signaling notable institutional interest in the stock from the Norwegian sovereign wealth manager.MarketBeat as of 06/01/2026

On the fundamental side, GE HealthCare Technologies reported its Q1 2026 earnings on 04/29/2026, posting earnings per share of USD 0.99 compared with a consensus estimate of USD 1.07, while revenue reached USD 5.13 billion, exceeding analyst expectations for the quarter, according to MarketBeat's earnings overview.MarketBeat earnings data as of 04/29/2026

The stock trades on Nasdaq under the ticker GEHC in the United States, which remains the core listing venue and reference market for pricing and liquidity in the name.

As of: 02/02/2026

By the editorial team - specialized in equity coverage.

GE HealthCare Technologies: core business model

GE HealthCare Technologies focuses on advanced imaging, monitoring and diagnostics equipment along with associated software and service contracts that generate recurring revenue across hospitals and healthcare providers globally.

Latest quarterly results for GE HealthCare Technologies at a glance

For Q1 2026, GE HealthCare Technologies delivered earnings per share of USD 0.99, which was USD 0.08 below the consensus estimate of USD 1.07 compiled by analysts, while quarterly revenue came in at USD 5.13 billion, modestly surpassing expectations based on data reported by MarketBeat on 04/29/2026.MarketBeat earnings overview as of 04/29/2026

MarketBeat also notes that, as of early June 2026, the company has not yet formally confirmed the date of its next earnings release, although an estimated reporting date around 07/29/2026 is inferred based on last year's schedule, which investors may monitor for updates from the investor relations site.MarketBeat earnings calendar as of 06/01/2026

Conclusion

The combination of a large new holding by Norges Bank and Q1 2026 earnings data that showed earnings per share below consensus but revenue slightly ahead keeps GE HealthCare Technologies firmly in focus for United States equity markets. With the next earnings date still to be confirmed and the company continuing to operate in a key segment of medical technology, investors are likely to follow upcoming disclosures and sector developments closely.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.